Automatic Abdominal Aortic Aneurysm Diameter Measurement

Sponsor
Natasha Monzon Svendsen (Other)
Overall Status
Completed
CT.gov ID
NCT05983016
Collaborator
Philips Healthcare (Industry)
29
1
2
30
29.4

Study Details

Study Description

Brief Summary

Managing abdominal aortic aneurysms currently relies on diameter assessment with ultrasound. Diameter reproducibility with two-dimensional ultrasound is challenging, and requires experienced operators. A novel automatic three-dimensional ultrasound system has the potential to facilitate more precise diameter measurements than two-dimensional ultrasound. This study aimed to assess the variance of abdominal aortic aneurysm diameter measurements among ultrasound novices and experts by comparing two-dimensional ultrasound with the three-dimensional ultrasound system in a clinical setting.

Ten patients under abdominal aortic aneurysm surveillance were examined by 29 ultrasound-operators: 13 experts and 16 novices. The experts were sonographers and physicians highly experienced in abdominal aortic aneurysm ultrasound, and the novices were medical students and junior residents with sparse ultrasound experience.

Condition or Disease Intervention/Treatment Phase
  • Device: Philips EPIQ-7, Philips Healthcare, Bothell, WA, USA
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
29 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
Double (Participant, Investigator)
Masking Description:
The study had a semi blinded setup. The ultrasound operators were not able to see the results of the segmentation software.
Primary Purpose:
Diagnostic
Official Title:
Automated Three-dimensional Ultrasound Bridges the Gap Between Novices and Experts in Diameter Assessment of Abdominal Aortic Aneurysms
Actual Study Start Date :
Jan 15, 2022
Actual Primary Completion Date :
Feb 14, 2022
Actual Study Completion Date :
Feb 14, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Novices

Novices measured abdominal aortic aneurysms in all patients using both two-dimensional and three-dimensional ultrasound

Device: Philips EPIQ-7, Philips Healthcare, Bothell, WA, USA
All patients had their abdominal aortic aneurysm maximum anterior-posterior diameter estimated with two-dimensional ultrasound using a 5 MHz curved array transducer (Philips® C5-1 transducer, Philips Healthcare, Bothell, WA, USA). After the acquisition, a three-dimensional ultrasound acquisition was performed with a 3D-matrix transducer (Philips® X6-1 transducers, Philips Healthcare, Bothell, WA, USA).

Experimental: Experts

Experts measured abdominal aortic aneurysms in all patients using both two-dimensional and three-dimensional ultrasound

Device: Philips EPIQ-7, Philips Healthcare, Bothell, WA, USA
All patients had their abdominal aortic aneurysm maximum anterior-posterior diameter estimated with two-dimensional ultrasound using a 5 MHz curved array transducer (Philips® C5-1 transducer, Philips Healthcare, Bothell, WA, USA). After the acquisition, a three-dimensional ultrasound acquisition was performed with a 3D-matrix transducer (Philips® X6-1 transducers, Philips Healthcare, Bothell, WA, USA).

Outcome Measures

Primary Outcome Measures

  1. Abdominal aortic aneurysm measurement variance between novices and experts [One week]

    The primary outcome was to test the variance of abdominal aortic aneurysm diameter measurements by comparing expert and novice ultrasound operators using conventional 2D-ultrasound and 3D-software assisted ultrasound.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Physicians who had performed more than 200 abdominal aortic aneurysm examinations within the last two years preceding the study.

  • Medical students or junior residents who had performed less than 5 unsupervised abdominal aortic aneurysm ultrasound scans.

  • Patients with abdominal aortic aneurysm > 3 cm.

Exclusion Criteria:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Vascular Surgery, Rigshospitalet Copenhagen Denmark 2300

Sponsors and Collaborators

  • Natasha Monzon Svendsen
  • Philips Healthcare

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Natasha Monzon Svendsen, MD, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT05983016
Other Study ID Numbers:
  • H-20001116
First Posted:
Aug 9, 2023
Last Update Posted:
Aug 9, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Natasha Monzon Svendsen, MD, Rigshospitalet, Denmark
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 9, 2023